These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 16546474)

  • 1. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
    Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
    Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome.
    Onat A; Hergenç G; Keleş I; Doğan Y; Türkmen S; Sansoy V
    Metabolism; 2005 Jun; 54(6):800-8. PubMed ID: 15931618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance.
    Meshkani R; Taghikhani M; Larijani B; Khatami S; Khoshbin E; Adeli K
    Clin Chim Acta; 2006 Sep; 371(1-2):169-75. PubMed ID: 16714005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study.
    Onat A; Hergenç G; Sari I; Türkmen S; Can G; Sansoy V
    Am J Hypertens; 2005 Mar; 18(3):409-16. PubMed ID: 15797662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum uric acid is a determinant of metabolic syndrome in a population-based study.
    Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Sari I; Yazici M; Keleş I
    Am J Hypertens; 2006 Oct; 19(10):1055-62. PubMed ID: 17027827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome.
    Onat A; Sari I; Yazici M; Can G; Hergenç G; Avci GS
    Int J Cardiol; 2006 Mar; 108(1):89-95. PubMed ID: 16085325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between mild renal dysfunction and insulin resistance or metabolic syndrome in a random nondiabetic population sample.
    Onat A; Hergenç G; Uyarel H; Ozhan H; Esen AM; Karabulut A; Albayrak S; Can G; Keleş I
    Kidney Blood Press Res; 2007; 30(2):88-96. PubMed ID: 17347575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein is elevated in obese patients with the metabolic syndrome.
    Florez H; Castillo-Florez S; Mendez A; Casanova-Romero P; Larreal-Urdaneta C; Lee D; Goldberg R
    Diabetes Res Clin Pract; 2006 Jan; 71(1):92-100. PubMed ID: 16002176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between Turkish Cardiovascular Risk Platform and United States National Cholesterol Education Program Adult Treatment Panel III definitions of the metabolic syndrome in Turkish adults.
    Can AS; Ozbayrakçi S; Palaoğlu KE; Bersot TP
    J Cardiometab Syndr; 2009; 4(1):26-32. PubMed ID: 19245513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
    Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
    Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.
    Jeppesen J; Hansen TW; Rasmussen S; Ibsen H; Torp-Pedersen C; Madsbad S
    J Am Coll Cardiol; 2007 May; 49(21):2112-9. PubMed ID: 17531661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Bertoni AG; Wong ND; Shea S; Ma S; Liu K; Preethi S; Jacobs DR; Wu C; Saad MF; Szklo M
    Diabetes Care; 2007 Nov; 30(11):2951-6. PubMed ID: 17704348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between n-3 and n-6 plasma fatty acid levels and insulin resistance in coronary patients with and without metabolic syndrome.
    Nigam A; Frasure-Smith N; Lespérance F; Julien P
    Nutr Metab Cardiovasc Dis; 2009 May; 19(4):264-70. PubMed ID: 18804984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.
    Rhee EJ; Kim YC; Lee WY; Jung CH; Sung KC; Ryu SH; Oh KW; Kim SW
    Metabolism; 2006 Feb; 55(2):183-7. PubMed ID: 16423624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body fat distribution and their associations with cardiovascular risk, insulin resistance and β-cell function: are there differences between men and women?
    Chen G; Liu C; Chen F; Yao J; Jiang Q; Chen N; Huang H; Liang J; Li L; Lin L
    Int J Clin Pract; 2011 May; 65(5):592-601. PubMed ID: 21489083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults.
    Onat A; Hergenç G; Karabulut A; Türkmen S; Doğan Y; Uyarel H; Can G; Sansoy V
    Prev Med; 2006 Aug; 43(2):136-9. PubMed ID: 16714057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.